Titanium alloy surface oxide modulates the conformation of adsorbed fibronectin to enhance its binding to α5β1 integrins in osteoblasts

European Journal of Oral Sciences

Volumn 120, Issue 3, 2012, Pages 185-194

  Rapuano, Bruce E ^a   Lee, Jani J E ^a   Macdonald, Daniel E ^a,b,c  

^a Cornell University ^*  (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Columbia University ^*  (United States)

Author keywords

Conformation; Fibronectin; Integrins; Osteoblast; Titanium alloy

Indexed keywords

BIOMATERIAL; FIBRONECTIN; TITANIUM; TITANIUM ALLOY (TIAL6V4); VERY LATE ACTIVATION ANTIGEN 5;

ADSORPTION; ANALYSIS OF VARIANCE; ANIMAL; ARTICLE; BONE REGENERATION; CELL ADHESION; CELL CULTURE; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECT; METALLURGY; MOUSE; OSTEOBLAST; PHYSIOLOGY; SURFACE PROPERTY;

ADSORPTION; ANALYSIS OF VARIANCE; ANIMALS; CELL ADHESION; CELLS, CULTURED; COATED MATERIALS, BIOCOMPATIBLE; FIBRONECTINS; INTEGRIN ALPHA5BETA1; METALLURGY; MICE; OSSEOINTEGRATION; OSTEOBLASTS; SURFACE PROPERTIES; TITANIUM;

EID: 84861228366     PISSN: 09098836     EISSN: 16000722     Source Type: Journal    
DOI: 10.1111/j.1600-0722.2012.954.x     Document Type: Article

References (51)

1. Webster TJ. Improved bone tissue engineering materials. Am Ceram Soc Bull 2003; 82: 23-28.
2. Adell R, Eriksen B, Lekholm U, Branemark PI, Jemt T. A long-term follow-up study of osseointegrated implants in the treatment of totally edentulous jaws. Int J Oral Maxillofac Implants 1990; 5: 347-359.
3. Adell R, Lekholm U, Rockler B, Branemark PI. A 15-year study of osseointegrated implants in the treatment of the edentulous jaw. Int J Oral Surg 1981; 10: 387-416.
4. Hardt CR, Grondahl K, Lekholm U, Wennstrom JL. Outcome of implant therapy in relation to experienced loss of periodontal bone support: A retrospective 5-year study. Clin Oral Implants Res 2002; 13: 488-494.
5. Friberg B, Sennerby L, Roos J, Johansson P, Strid KG, Lekholm U. Evaluation of bone density using cutting resistance measurements and microradiography: an in vitro study in pig ribs. Clin Oral Implants Res 1995; 6: 164-171.
6. Williams DF. Implants in dental and maxillofacial surgery. Biomaterials 1981; 2: 133-146.
7. Imam MA, Fraker AC. Titanium alloys as implant materials. In: Brown SA, Lemons JE, eds. Medical applications of titanium and its alloys. Philadelphia: American Society for Testing and Materials, 1996; 3-16.
8. Morris HF, Winkler S, Ochi S. A 48-month multicenter clinical investigation: implant design and survival. J Oral Implantol 2001; 27: 180-186.
9. Kasemo B. Biocompatibility of titanium implants: surface science aspects. J Prosthetic Dent 1983; 49: 832-837.
10. 2 depends on the competitive preadsorption of albumin and fibronectin. J Biomed Mater Res A 2008; 84: 281-290.
11. Garcia A, Reyes C. Bio-adhesive surfaces to promote osteoblast differentiation and bone formation. J Dent Res 2005; 84: 407-413.
12. Sieving A, Wu B, Mayton L, Nasser S, Wooley PH. Morphological characteristics of total joint arthroplasty-derived ultra-high molecular weight polyethylene (UHMWPE) wear debris that provoke inflammation in a murine model of inflammation. J Biomed Mater Res 2003; 64A: 457-464.
13. Rapuano BE, Wu C, Macdonald DE. Osteoblast-like cell adhesion to bone sialoprotein peptides. J Orthop Res 2004; 22: 353-361.
14. Sauberlich S, Klee D, Richter EJ, Hocker H, Spiekermann H. Cell culture tests for assessing the tolerance of soft tissue to variously modified titanium surfaces. Clin Oral Implants Res 1999; 10: 379-393.
15. Macdonald DE, Deo N, Markovic B, Stranick M, Somasundaran P. Adsorption and dissolution behavior of human plasma fibronectin on thermally and chemically modified titanium dioxide particles. Biomaterials 2002; 23: 1269-1279.
16. Macdonald DE, Markovic B, Allen M, Somasundaran P, Boskey AL. Surface analysis of human plasma fibronectin adsorbed to commercially pure titanium materials. J Biomed Materials Res 1998; 41: 120-130.
17. Harbers GM, Healy KE. The effect of ligand type and density on osteoblast adhesion, proliferation, and matrix mineralization. J Biomed Mater Res 2005; 75: 855-869.
18. Barber TA, Golledge SI, Castner DG, Healy KE. Peptide-modified p(AAm-co-EG/AAc) IPN's grafted to bulk titanium modulate osteoblast behavior in vitro. J Biomed Mater Res 2003; 64: 38-47.
19. Rezania A, Thomas CH, Branger AB, Waters CM, Healy KE. The detachment strength and morphology of bone cells contacting materials modified with a peptide sequence found within bone sialoprotein. J Biomed Mater Res 1997; 37: 9-19.
20. Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell 2002; 110: 673-687.
21. Macdonald DE, Rapuano BE, Deo N, Stranick M, Somasundaran P, Boskey AL. Thermal and chemical modification of titanium-aluminum-vanadium implant materials: effects on surface properties, glycoprotein adsorption, and MG63 cell attachment. Biomaterials 2004; 25: 3135-3146.
22. Rapuano BE, Macdonald DE. Surface oxide net charge of a titanium alloy: modulation of fibronectin-activated attachment and spreading of osteogenic cells. Colloids and Surface B. Biointerfaces 2011; 82: 95-103.
23. Macdonald DE, Rapuano BE, Schniepp HC. Surface oxide net charge of a titanium alloy: comparison between effects of treatment with heat or radiofrequency plasma glow discharge. Colloids and Surface B Biointerfaces 2011; 82: 173-181.
24. Bergkvist M, Carlsson J, Oscarsson S. Surface-dependent conformations of human plasma fibronectin adsorbed to silica, mica, and hydrophobic surfaces, studied with use of atomic force microscopy. J Biomed Mater Res 2003; 64A: 349-356.
25. Baugh L, Vogel V. Structural changes of fibronectin adsorbed to model surfaces probed by fluorescence resonance energy transfer. J Biomed Mater Res 2004; 69A: 525-534.
26. Kowalczynska HM, Kolos R, Nowak-Wyrzykowska M, Dobkowski J, Elbaum D, Szczepankiewicz A, Kamin J. Atomic force microscopy evidence for conformational changes of fibronectin adsorbed on unmodified and sulfonated polystyrene surfaces. J Biomed Mater Res 2009; 91A: 1239-1251.
27. Miller T, Boettiger D. Control of intracellular signaling by modulation of fibronectin conformation at the cell-materials interface. Langmuir 2003; 19: 1723-1729.
28. 1 integrin interaction and cellular attachment. Biomaterials 2006; 27: 1907-1916.
29. Keselowsky BG, Garcia AJ. Quantitative methods for analysis of integrin binding and focal adhesion formation on biomaterial surfaces. Biomaterials 2005; 26: 413-418.
30. Bowditch RD, Halloran CE, Aota S, Obara M, Plow EF, Yamada KM, Ginsberg MH. Integrin alpha IIb beta 3 (platelet GPIIb-IIIa) recognizes multiple sites in fibronectin. J Biol Chem 1991; 266: 23323-23328.
31. Danen EH, Aota S, Van Kraats AA, Yamada KM, Ruiter DJ, Van Munjen GN. Requirement for the synergy site for cell adhesion to fibronectin depends on the activation state of integrin alpha 5 beta 1. J Biol Chem 1995; 270: 21612-21618.
32. Argraves WS, Suzuki S, Arai H, Thompson K, Pierschbacher MD, Ruoslahti E. Amino acid sequence of the human fibronectin receptor. J Cell Biol 1987; 105: 1183-1190.
33. Bennett KL, Kussman M, Bjork P, Godzwon M, Mikkelsen M, Sorensen P, Roepstorff P. Chemical cross-linking with thiol-cleavable reagents combined with different mass spectrometric peptide mapping - a novel approach to assess intermolecular protein contacts. Protein Sci 2000; 9: 1503-1518.
34. Aota S, Nomizu M, Yamada KM. The short amino acid sequence Pro-His-Ser-Arg-Asn in human fibronectin enhances cell-adhesive function. J Biol Chem 1994; 269: 24756-24761.
35. Redick SD, Settles DL, Briscoe G, Erickson HP. Defining fibronectin's cell adhesion synergy site by site-directed mutagenesis. J Cell Biol 2000; 149: 521-527.
36. 1 integrin show differential binding to RGD and synergy domains of fibronectin. Biochemistry 2002; 41: 9063-9069.
37. Wang Z, Telci D, Griffin M. Importance of syndecan-4 and syndecan -2 in osteoblast cell adhesion and survival mediated by a tissue transglutaminase-fibronectin complex. Exp Cell Res 2011; 317: 367-381.
38. Woods A, Couchman JR, Johansson S, Hook M. Adhesion and cytoskeletal organization of fibroblasts in response to fibronectin fragments. EMBO J 1986; 5: 665-670.
39. Bloom L, Ingham KC, Hynes RO. Fibronectin regulates assembly of actin filaments and focal contacts in cultured cells via the heparin-binding site in repeat III13. Mol Biol Cell 1999; 10: 1521-1536.
40. Bass MD, Humphries MJ. Cytoplasmic interactions of syndecan-4 orchestrate adhesion receptor and growth factor receptor signaling. Biochem J 2002; 368: 1-15.
41. Couchman JR. Syndecans : proteoglycan regulators of cell surface microdomains?Nat Rev Mol Cell Biol 2003; 4: 926-937.
42. Ingham KC, Brew SA, Atha DH. Interaction of heparin with fibronectin and isolated fibronectin domains. Biochem J 1990; 272: 605-611.
43. Park JW, Kim YJ, Jang JH, Song H. Osteoblast response to magnesium ion-incorporated nanoporous titanium oxide sufaces. Clin Oral Implants Res 2011; 21: 1278-1587.
44. Yang RS, Lin WL, Chen YZ, Tang CH, Huang TH, Lu BY, Fu WM. Regulation by ultrasound treatment on the integrin expression and differentiation of osteoblasts. Bone 2005; 36: 276-283.
45. Vargo TG, Bekos EJ, Kim YS, Ranieri JP, Bellamkonda R, Aebischer P, Margevich DE, Thompson PM, Bright FV, Gardella JA Jr. Synthesis and characterization of fluoropolymeric substrata with immobilized minimal peptide sequences for cell adhesion studies. I. J Biomed. Mater Res 1995; 29: 767-778.
46. Hamrnikova I, Miksik I, Deyl Z, Kasicka V. Binding of proline and hydroxyprolin-containing peptides to the capillary wall. J Chromatogr 1999; 838: 167-177.
47. Murgida DH, Hildebrandt P. Surface-enhanced resonance raman spectroscopic and electrochemical study of cytochrome c bound on electrodes through coordination with pyridinyl-terminated self-assembled monolayers. J Phys Chem 2004; 108: 2261-2269.
48. Vuento M, Stenman U-H, Salonen E, Osterlund K, Kuuselas P. Effect of chemical modification of arginine and lysine residues of fibronectin on its antigenic and gelatin-binding activity. Mol Immunol 1983; 20: 149-153.
49. Keselowsky BG, Collard DM, Garcia AJ. Surface chemistry modulates fibronectin conformation and directs integrin binding and specificity to control cell adhesion. J Biomed Mater Res 2003; 66A: 247-259.
50. Leahy DJ, Aukhil I, Erickson HP. 2.0 Å crystal structure of a four-domain segment of human fibronectin encompassing the RGD loop and synergy region. Cell 1996; 84: 155-164.
51. Grant RP, Spitzfaden C, Altroff H, Campbell ID, Mardon HJ. Structural requirements for biological activity of the ninth and tenth FIII domains of human fibronectin. J Biol Chem 1997; 272: 6159-6166.